Model Checkpoint Epoch: 5.0
Evaluation Model Used: gpt-5
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Low BF% is an indicator of undernutrition in neonates and has been linked to increased risk of neonatal morbidity. However, whether BF% or birth weight percentiles are more useful measures of undernutrition requires further investigation. In this study, we showed that both BF% and birth weight percentiles can be used as measures of undernutrition in neonates. BF% is associated with an increased risk of neonatal morbidity, whereas birth weight percentiles are also associated with neonatal morbidity but to a lesser extent. Thus, BF% may be a better measure of undernutrition in neonates. However, further studies are required to confirm these findings and to determine which measure should be used when evaluating the effects of undernutrition on neonatal health.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.8
Reasoning:
The study shows that lower BF% has a stronger association with neonatal morbidity than birth weight percentiles (OR 1.30 vs 1.03), indicating BF% is a better marker of undernutrition in this population. The assistant’s answer captures that BF% is more strongly associated but hedges with unnecessary uncertainty (“may be” and “requires further investigation”) and doesn’t note BF% helps identify undernourished neonates who are appropriately grown and exclude small neonates not at risk. Overall, it is mostly correct but less definitive than warranted.

conciseness: 0.6
Reasoning:
The answer eventually states that BF% may be a better measure, but it is wordier than necessary and includes repetitive hedging about needing further studies. It could have concisely stated that BF% is more closely associated with neonatal morbidity than birth weight percentiles, directly answering the question.

relevance: 0.6
Reasoning:
The response is mostly relevant: it answers the question and reflects the context that both metrics are associated with morbidity, with BF% showing a stronger association, implying it may be a better measure. However, it hedges more than the ground truth and does not include or explicitly reference a direct quote from the provided context, which the evaluation prioritizes.

coherence: 0.8
Reasoning:
The response is coherent and generally well-structured. It introduces the concept (BF% as an indicator), acknowledges both measures, notes that BF% shows a stronger association with morbidity, and cautiously concludes that BF% may be better while calling for further research. The narrative flows logically without contradictions, though it is somewhat repetitive and uses an odd self-reference (“we showed”), and the hedging could be tighter. Overall, it answers the question directly and coherently.

helpfulness: 0.7
Reasoning:
The answer acknowledges that both BF% and birth weight percentiles are associated with neonatal morbidity and correctly suggests BF% shows a stronger association, implying it may be a better measure. However, it is overly hedged, lacks the clear conclusion supported by the study that BF% is more closely associated in this population, and omits the useful nuance that BF% can identify appropriately grown but undernourished neonates and exclude small neonates not at risk. It also misses citing the comparative strength (e.g., ORs) to substantiate the claim.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: The results of this study confirm that the presence of foot ulcers in diabetic patients with ischemic Charcot neuropathy may be treated successfully by revascularization, surgery and orthopedics. However, it is important to note that these treatments should be tailored to each patient according to the severity of the condition, as well as its associated complications. The use of endovascular revascularization should be reserved for cases where there is good vascularization of the foot, while surgery should be considered when there is a large amount of necrotic tissue or gangrene. Finally, the use of orthopedic procedures such as osteotomy or arthroplasty should be considered when there is a high risk of infection or if there is an associated bone deformity. Therefore, it is essential to individualize the treatment approach and to consider the severity and extent of the condition in order to achieve the best possible outcome.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.3
Reasoning:
The answer captures the general idea that ischemic Charcot foot can be managed with revascularization plus surgical and orthopedic care, aligning partially with the study’s conclusion. However, it contains a key factual error: revascularization is indicated for poor/critical limb perfusion, not when there is “good vascularization.” It also omits the study’s specific outcomes (90% limb salvage, ~197 days to heal) and does not clearly state that revascularization is necessary to support limb salvage, which is central to the ground truth. Overall, correctness is compromised.

conciseness: 0.3
Reasoning:
The response is wordy and indirect. It adds generic caveats about individualized treatment and speculative criteria, instead of concisely delivering the core takeaway: ischemic Charcot foot requires revascularization alongside surgical and orthopedic management to avoid major amputation and achieve limb salvage. It also omits the key outcome figures, making it less to-the-point.

relevance: 0.3
Reasoning:
The response is somewhat relevant, as it mentions treating ischemic Charcot foot with revascularization plus surgical and orthopedic management. However, it does not cite or paraphrase a specific quote from the provided context, which reported 90% limb salvage and emphasized the necessity of revascularization to support surgery/orthopedics. It also introduces unsupported and contradictory statements (e.g., reserving endovascular revascularization for cases with good vascularization), and it fails to directly address the “different disease with different treatment” framing. Overall, it lacks a direct, contextual quote and key study details.

coherence: 0.5
Reasoning:
The response is generally organized and stays on topic, emphasizing a multimodal approach (revascularization, surgery, orthopedics) consistent with the context. However, it contains confusing and internally inconsistent guidance (e.g., suggesting endovascular revascularization for cases with good vascularization) and vague indications for orthopedic procedures. It also doesn’t directly address the “different disease with different treatment” framing or clearly connect to limb-salvage outcomes. These issues reduce coherence despite an overall reasonable structure.

helpfulness: 0.3
Reasoning:
The answer captures the general idea that ischemic Charcot foot with ulcers can be managed using a combination of revascularization, surgery, and orthopedic measures, aligning somewhat with the ground truth. However, it fails to directly address the question of whether it represents a “different disease with different treatment,” and it omits key outcome data (90% limb salvage, ~197 days to heal). It also includes questionable statements (e.g., reserving revascularization for cases with good vascularization, and suggesting orthopedics primarily for high infection risk), which are misleading. Overall, it is generic and not sufficiently tailored to the provided context.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: The results suggest that RH should be considered for endometrial cancer patients with suspected cervical involvement, especially when they have advanced disease or high risk features. This operation is safe in terms of morbidity and mortality, but it may be more effective than mRH or SH. It is also suggested that age, tumor grade, peritoneal cytology status, and lymph node involvement are important prognostic factors for OS. However, the type of surgery does not affect local recurrence-free survival, PFS, or OS. Therefore, RH could be considered as a treatment option for endometrial cancer patients with suspected cervical involvement. Further studies are required to confirm these findings.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.3
Reasoning:
The assistant’s answer conflicts with the study’s findings. The study found no survival benefit from radical hysterectomy (RH) and identified higher perioperative and late adverse events with RH (longer operative time, more transfusions, more severe urinary dysfunction). The answer incorrectly suggests RH may be more effective and “safe,” and recommends considering RH, which contradicts the evidence. It does correctly mention that age, grade, peritoneal cytology, and lymph node status are prognostic for OS and that the type of hysterectomy was not an independent prognostic factor, but the overall conclusion is misleading.

conciseness: 0.2
Reasoning:
The response is not concise or to the point relative to the study’s findings. It includes contradictory and unnecessary statements (e.g., suggesting RH should be considered and is safe, while also saying surgery type doesn’t affect outcomes), and it omits the key concise takeaway that RH confers no survival benefit and has higher adverse events. A concise answer should have stated that RH is not needed based on no survival advantage and more complications, with a note for prospective evaluation.

relevance: 0.2
Reasoning:
The response partly addresses the study but contradicts key findings from the context and ground truth. While it correctly notes that the type of hysterectomy did not affect PFS or OS and lists the prognostic factors (age, grade, peritoneal cytology, lymph nodes), it incorrectly suggests RH may be more effective and is safe, which conflicts with the context stating no survival benefit and higher perioperative and late adverse events (e.g., longer operative time, more transfusions, severe urinary dysfunction) in the RH group. It also does not reference any direct quote from the context.

coherence: 0.3
Reasoning:
The response is poorly coherent. It makes contradictory claims: it first suggests RH should be considered and “may be more effective,” yet also states that the type of surgery does not affect survival outcomes. It calls RH “safe in terms of morbidity,” while the study reports higher adverse events with RH. These inconsistencies create a confusing message about whether RH is needed. Although the response is structured as a single paragraph and mentions relevant prognostic factors, the internal contradictions undermine coherence.

helpfulness: 0.2
Reasoning:
The response is misleading and internally inconsistent relative to the study’s findings. While it correctly notes that age, grade, peritoneal cytology, and lymph node status are prognostic and that the type of hysterectomy did not affect survival outcomes, it incorrectly suggests RH “should be considered” and “may be more effective,” and characterizes it as safe without acknowledging the higher complication rates reported (longer operative time, more transfusions, urinary dysfunction). The answer does not clearly address the core question—whether RH is needed—and fails to convey the study’s key conclusion that there was no survival benefit from RH and more adverse events, implying RH is not routinely necessary. Overall, it is not helpful.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: We believe that readmissions after PD may be preventable by improving patient selection, optimizing preoperative care, and refining operative techniques. Our results suggest that patients requiring readmission after PD had an increased risk of pancreatic fistula, multivisceral resection, prolonged initial hospital stays, ICU admissions, and prolonged hospitalization. These factors should be considered during the perioperative evaluation of patients undergoing PD. Moreover, we propose that a multifaceted approach incorporating standardized protocols for management of readmissions, enhanced communication between surgeons and primary care physicians, and development of specialized postoperative care units could reduce the number of readmissions after PD. Future studies should focus on identifying specific perioperative factors associated with readmissions and implementing evidence-based strategies to minimize their occurrence.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.5
Reasoning:
The response identifies some relevant risk factors (pancreatic fistula and multivisceral/complex resection) but adds others as independently associated that are not emphasized in the ground truth. More importantly, it fails to highlight the key takeaway that half of readmissions occur early and that prevention efforts should focus on early readmissions. The proposed strategies are generic and speculative rather than grounded in the study’s specific conclusions.

conciseness: 0.4
Reasoning:
The response is verbose and includes generic, speculative recommendations not grounded in the provided findings. While it mentions pancreatic fistula and multivisceral resection as risk factors, it omits the key takeaway that half of readmissions occur within 7 days and that prevention should focus on early readmissions. Overall, it is not concise or tightly aligned with the core answer.

relevance: 0.6
Reasoning:
The response is generally relevant: it discusses prevention and mentions real predictors from the context (pancreatic fistula, multivisceral resection, longer initial stay, ICU admission). However, it does not emphasize the key contextual finding that half of readmissions occur within 7 days and that efforts should focus on preventing early readmissions. It also does not provide a direct quote from the context and introduces speculative strategies not grounded in the provided text.

coherence: 0.7
Reasoning:
The response is coherent and generally well-structured. It identifies key risk factors (pancreatic fistula, multivisceral resection, longer initial stay, ICU admission) and ties them to potential prevention strategies, maintaining logical flow. However, it is somewhat generic, includes minor redundancy (“prolonged initial hospital stays” and “prolonged hospitalization”), and does not highlight the key point that half of readmissions occur within 7 days and that efforts should focus on preventing early readmissions. Despite this, it answers the question in a clear and organized manner.

helpfulness: 0.6
Reasoning:
The response captures key predictors of readmission identified in the study (pancreatic fistula, multivisceral resection, longer initial stay, ICU admission) and proposes a general prevention framework. However, it misses the study’s main actionable takeaway: half of readmissions occur within 7 days and efforts should focus on preventing early readmissions. It also lacks specificity about early vs late causes (e.g., ileus, delayed gastric emptying, pneumonia early) and gives generic recommendations rather than targeted strategies based on the data.

================================================================================
Average correctness Score: 0.45
Average conciseness Score: 0.395
Average relevance Score: 0.43
Average coherence Score: 0.575
Average helpfulness Score: 0.44
